Amgen Inc.

Exporter
1 Amgen Center Dr., Thousand Oaks, CA 91320-1730, United States
(805)447-1000, (805)447-1010 fax, http://www.amgen.com

Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Amgen Inc. was incorporated in 1980 and is a global biotechnology company that discovers, develops, manufactures and markets human therapeutics. Amgen markets human therapeutic products in the areas of supportive cancer care, nephrology, inflammation and oncology to healthcare providers including physicians, clinics, dialysis centers, hospitals and pharmacies. The company focuses research and development efforts on novel therapeutics for the treatment of grievous illness in the core areas of oncology, inflammation, bone and metabolic disorders. Amgen's manufacturing operations consist of bulk manufacturing, formulation, fill and finish activities for both commercial and clinical purposes. The company operates in one business segment - human therapeutics. Amgen maintains sales and marketing forces primarily in the United States, Europe and Canada. In the United States, the company sells primarily to wholesale distributors of pharmaceutical products. Outside the United States, Amgen sells principally to hospitals and wholesalers. The company has major research and development centers in several locations throughout the United States and in the United Kingdom, and has smaller centers in other countries throughout the world. Amgen operates commercial and clinical manufacturing facilities in several locations throughout the United States and in Puerto Rico. The company's principal products include Aranesp, EPOGEN, Neulasta, NEUPOGEN and Enbrel. More

Manufacturing: Develops and manufactures human therapeutics based on advanced cellular and molecular biology.